Recent updates state a significant
83.9% decrease in Short Interest in
BAS. Along with this, some market analysts suggest it's time to consider buying
BASF SE due to potential underselling. However, other analysts have given
BASFY a Consensus Rating of '
Reduce'. Despite these mixed reviews, it continues to be seen as a top dividend stock. Possible changes are being considered to potentially cut jobs in their battery materials plant. Yet
BASF is also extending Basoflux production capacity in Tarragona and has maintained its 2024 outlook despite a Q1 sales dip. The firm has revealed a New Natural Flavor in its Isobionics Portfolio, and also the
Loopamid, a recycled nylon developed with
Inditex. However, there is worry concerning its financial prospects and a somewhat strained balance sheet. An intrinsic calculation for the chemical giant suggests it could be 26% undervalued. Despite a slight slump in Q1 earnings, overall performance has kept BASF's popularity amongst investors intact.
BASF Stocks News Analytics from Tue, 01 May 2018 07:00:00 GMT to Wed, 29 May 2024 14:55:55 GMT -
Rating -1
- Innovation 1
- Information 4
- Rumor -3
